235 related articles for article (PubMed ID: 2488380)
1. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Fuiano G; Sepe V; Viscione M; Nani E; Conte G
Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
5. The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment.
Dahl K; Walstad RA; Widerøe TE
Nephrol Dial Transplant; 1990; 5(4):275-81. PubMed ID: 2113224
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
7. A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Cheng IK; Chan CY; Wong WT
Perit Dial Int; 1991; 11(1):27-30. PubMed ID: 2049419
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
[TBL] [Abstract][Full Text] [Related]
9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
10. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
Were AJ; Marsden A; Tooth A; Ramsden R; Mistry CD; Gokal R
Clin Nephrol; 1992 Apr; 37(4):209-13. PubMed ID: 1582059
[TBL] [Abstract][Full Text] [Related]
11. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
12. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
Lui SF; Cheng AB; Leung CB; Wong KC; Li PK; Lai KN
Am J Nephrol; 1994; 14(3):182-6. PubMed ID: 7977477
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
Weber J; Staerz E; Mettang T; Machleidt C; Kuhlmann U
Perit Dial Int; 1989; 9(3):191-5. PubMed ID: 2488364
[TBL] [Abstract][Full Text] [Related]
15. Cefoperazone in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients.
Leehey DJ; Reid R; Chan AY; Ing TS
Artif Organs; 1988 Dec; 12(6):482-3. PubMed ID: 3214327
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
18. Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).
Dryden MS; Wing AJ; Phillips I
J Antimicrob Chemother; 1991 Jul; 28(1):131-9. PubMed ID: 1769932
[TBL] [Abstract][Full Text] [Related]
19. Cephalexin for the oral treatment of CAPD peritonitis.
Drew PJ; Casewell MW; Desai N; Houang ET; Simpson CN; Marsh FP
J Antimicrob Chemother; 1984 Feb; 13(2):153-9. PubMed ID: 6368518
[TBL] [Abstract][Full Text] [Related]
20. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
